IAVI, Merck KGaA, Darmstadt, Germany, and Serum Institute of India Join Forces to Develop Monoclonal Antibodies for COVID-19 and Ensure Prompt and Equitable Global Access
Partners aim to provide potent neutralizing antibodies for COVID-19 pandemic response Promising COVID-19 treatment being…